FDA Would Lose Direct Access To User Fees Under House Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA would lose the ability to negotiate with user fee payors on use of the funds under legislation introduced by Rep. Hinchey (D-N.Y.). The bill also would place restrictions on advisory committee members with financial ties to the industry.